The integrated landscape of driver genomic alterations in glioblastoma

[1]  G. Privé,et al.  Crystal Structure of KLHL3 in Complex with Cullin3 , 2013, PloS one.

[2]  S. Knapp,et al.  Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases. , 2013, The Journal of Biological Chemistry.

[3]  K. Aldape,et al.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. , 2013, The Journal of clinical investigation.

[4]  H. Cross,et al.  Mutation of HERC2 causes developmental delay with Angelman-like features , 2012, Journal of Medical Genetics.

[5]  Luciana Romão,et al.  Glioblastoma: therapeutic challenges, what lies ahead. , 2012, Biochimica et biophysica acta.

[6]  Sudha Seshadri,et al.  δ-Catenin Is Genetically and Biologically Associated with Cortical Cataract and Future Alzheimer-Related Structural and Functional Brain Changes , 2012, PloS one.

[7]  D. Brat,et al.  Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma , 2012, Science.

[8]  Joshy George,et al.  LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin. , 2012, Cancer research.

[9]  Steven J. M. Jones,et al.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes , 2012, Nature.

[10]  John L Rubinstein,et al.  Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase. , 2012, Structure.

[11]  Jill P. Mesirov,et al.  MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS , 2012, Nature.

[12]  D. Bernardo,et al.  Id proteins synchronize stemness and anchorage to the niche of neural stem cells , 2012, Nature Cell Biology.

[13]  Paul S Mischel,et al.  Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. , 2012, Cancer discovery.

[14]  Lynda Chin,et al.  Emerging insights into the molecular and cellular basis of glioblastoma. , 2012, Genes & development.

[15]  X. Estivill,et al.  KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron , 2012, Nature Genetics.

[16]  T. Willnow,et al.  LRP2 is an auxiliary SHH receptor required to condition the forebrain ventral midline for inductive signals. , 2012, Developmental cell.

[17]  Jai Radhakrishnan,et al.  Mutations in Kelch-like 3 and Cullin 3 cause hypertension and electrolyte abnormalities , 2012, Nature.

[18]  Matthew W. Wilson,et al.  A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.

[19]  Christopher A. Maher,et al.  ChimeraScan: a tool for identifying chimeric transcription in sequencing data , 2011, Bioinform..

[20]  Michael J. Emanuele,et al.  Global Identification of Modular Cullin-RING Ligase Substrates , 2011, Cell.

[21]  Kristian Cibulskis,et al.  Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion , 2011, Nature Genetics.

[22]  S. Pileri,et al.  BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.

[23]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[24]  Marek Kimmel,et al.  Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed , 2011, Human mutation.

[25]  A. Katritzky,et al.  Chemokine receptor CXCR3 promotes growth of glioma. , 2011, Carcinogenesis.

[26]  Michael J. Lush,et al.  genenames.org: the HGNC resources in 2011 , 2010, Nucleic Acids Res..

[27]  Sally Freels,et al.  Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. , 2010, Neuro-oncology.

[28]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[29]  Yang Zhang,et al.  I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.

[30]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[31]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[32]  Wei Keat Lim,et al.  The transcriptional network for mesenchymal transformation of brain tumors , 2009, Nature.

[33]  Mingming Jia,et al.  COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer , 2009, Nucleic Acids Res..

[34]  A. Chinnaiyan,et al.  Chromosomal aberrations in solid tumors. , 2010, Progress in molecular biology and translational science.

[35]  N. Mailand,et al.  HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes , 2010, Nature Cell Biology.

[36]  Alan F. Rubin,et al.  Mutation patterns in cancer genomes , 2009, Proceedings of the National Academy of Sciences.

[37]  J Wade Harper,et al.  Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. , 2009, Molecular cell.

[38]  Wei Keat Lim,et al.  The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. , 2009, Developmental cell.

[39]  Guoping Fan,et al.  BCOR regulates mesenchymal stem cell function by epigenetic mechanisms , 2009, Nature Cell Biology.

[40]  E. Ullian,et al.  δ-Catenin Regulates Spine and Synapse Morphogenesis and Function in Hippocampal Neurons during Development , 2009, The Journal of Neuroscience.

[41]  Albert J. Vilella,et al.  EnsemblCompara GeneTrees: Complete, duplication-aware phylogenetic trees in vertebrates. , 2009, Genome research.

[42]  K. Kosik,et al.  A δ-Catenin Signaling Pathway Leading to Dendritic Protrusions* , 2008, Journal of Biological Chemistry.

[43]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[44]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[45]  J. A. Wamstad,et al.  Role of the Transcriptional Corepressor Bcor in Embryonic Stem Cell Differentiation and Early Embryonic Development , 2008, PloS one.

[46]  M. Budoff,et al.  National Institute of Neurological Disorders and Stroke , 2008 .

[47]  A. Iavarone,et al.  The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein , 2008, Nature Cell Biology.

[48]  M. Westphal,et al.  Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.

[49]  Dian Donnai,et al.  Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes , 2007, Nature Genetics.

[50]  J. A. Wamstad,et al.  Characterization of Bcor expression in mouse development. , 2007, Gene expression patterns : GEP.

[51]  M. Hannink,et al.  Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling , 2006, The EMBO journal.

[52]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[53]  H. Augustin,et al.  The BTB-kelch Protein LZTR-1 Is a Novel Golgi Protein That Is Degraded upon Induction of Apoptosis* , 2006, Journal of Biological Chemistry.

[54]  M. Pierotti,et al.  Oncogenic rearrangements of the NTRK1/NGF receptor. , 2006, Cancer letters.

[55]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Stogios,et al.  Sequence and structural analysis of BTB domain proteins , 2005, Genome Biology.

[57]  M. Lieberman,et al.  Ubiquitination of Keap1, a BTB-Kelch Substrate Adaptor Protein for Cul3, Targets Keap1 for Degradation by a Proteasome-independent Pathway* , 2005, Journal of Biological Chemistry.

[58]  Johannes Söding,et al.  Protein homology detection by HMM?CHMM comparison , 2005, Bioinform..

[59]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[60]  K. Kosik,et al.  δ-Catenin at the synaptic–adherens junction , 2005 .

[61]  K. Kosik,et al.  Delta-catenin at the synaptic-adherens junction. , 2005, Trends in cell biology.

[62]  Alcino J. Silva,et al.  Deletion of the Neuron-Specific Protein Delta-Catenin Leads to Severe Cognitive and Synaptic Dysfunction , 2004, Current Biology.

[63]  David T. Jones,et al.  β Propellers: structural rigidity and functional diversity , 1999 .

[64]  M. Peter,et al.  Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  D. van der Kooy,et al.  Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. , 1999, Developmental biology.

[66]  D. T. Jones,et al.  Beta propellers: structural rigidity and functional diversity. , 1999, Current opinion in structural biology.

[67]  D K Burns,et al.  Defective forebrain development in mice lacking gp330/megalin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[68]  L. Muhlbaier,et al.  Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. , 1988, Cancer Research.